nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—AKT1—ovarian cancer	0.395	0.851	CbGaD
Adenosine triphosphate—ABCB1—ovarian cancer	0.0689	0.149	CbGaD
Adenosine triphosphate—ABCB11—Paclitaxel—ovarian cancer	0.0471	0.238	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—ovarian cancer	0.0254	0.128	CbGbCtD
Adenosine triphosphate—ABCC2—Paclitaxel—ovarian cancer	0.0248	0.125	CbGbCtD
Adenosine triphosphate—ABCC2—Carboplatin—ovarian cancer	0.0233	0.118	CbGbCtD
Adenosine triphosphate—ABCC2—Docetaxel—ovarian cancer	0.0179	0.0905	CbGbCtD
Adenosine triphosphate—ABCB1—Topotecan—ovarian cancer	0.0163	0.0824	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—ovarian cancer	0.0133	0.0675	CbGbCtD
Adenosine triphosphate—ABCB1—Vinorelbine—ovarian cancer	0.0115	0.0581	CbGbCtD
Adenosine triphosphate—ABCB1—Paclitaxel—ovarian cancer	0.00807	0.0408	CbGbCtD
Adenosine triphosphate—ABCB1—Docetaxel—ovarian cancer	0.00584	0.0295	CbGbCtD
Adenosine triphosphate—ABCB1—Doxorubicin—ovarian cancer	0.00435	0.022	CbGbCtD
Adenosine triphosphate—Tenofovir—NME2—ovarian cancer	0.00352	1	CrCbGaD
Adenosine triphosphate—HSPA1A—Irinotecan—Topotecan—ovarian cancer	0.000901	0.215	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Vindesine—Vinorelbine—ovarian cancer	0.000669	0.16	CbGdCrCtD
Adenosine triphosphate—ACSL1—myometrium—ovarian cancer	0.000659	0.00444	CbGeAlD
Adenosine triphosphate—ARAF—endometrium—ovarian cancer	0.000652	0.0044	CbGeAlD
Adenosine triphosphate—NAE1—uterine cervix—ovarian cancer	0.000652	0.00439	CbGeAlD
Adenosine triphosphate—ASNA1—decidua—ovarian cancer	0.000644	0.00435	CbGeAlD
Adenosine triphosphate—ADRBK2—bone marrow—ovarian cancer	0.000644	0.00434	CbGeAlD
Adenosine triphosphate—HSPA1B—uterus—ovarian cancer	0.000642	0.00433	CbGeAlD
Adenosine triphosphate—HSPA1A—uterus—ovarian cancer	0.000642	0.00433	CbGeAlD
Adenosine triphosphate—ADRBK2—female gonad—ovarian cancer	0.000621	0.00419	CbGeAlD
Adenosine triphosphate—NAE1—decidua—ovarian cancer	0.000621	0.00419	CbGeAlD
Adenosine triphosphate—ACVRL1—female reproductive system—ovarian cancer	0.000619	0.00417	CbGeAlD
Adenosine triphosphate—ADRBK2—vagina—ovarian cancer	0.000617	0.00416	CbGeAlD
Adenosine triphosphate—ASNA1—endometrium—ovarian cancer	0.000612	0.00412	CbGeAlD
Adenosine triphosphate—ARAF—gonad—ovarian cancer	0.000605	0.00408	CbGeAlD
Adenosine triphosphate—AFG3L2—endometrium—ovarian cancer	0.000604	0.00407	CbGeAlD
Adenosine triphosphate—ARAF—uterus—ovarian cancer	0.000601	0.00405	CbGeAlD
Adenosine triphosphate—NAE1—endometrium—ovarian cancer	0.000589	0.00397	CbGeAlD
Adenosine triphosphate—AMHR2—lymph node—ovarian cancer	0.000588	0.00397	CbGeAlD
Adenosine triphosphate—ACVR1B—gonad—ovarian cancer	0.000587	0.00396	CbGeAlD
Adenosine triphosphate—SLC25A4—decidua—ovarian cancer	0.000578	0.0039	CbGeAlD
Adenosine triphosphate—AKT1—myometrium—ovarian cancer	0.000569	0.00384	CbGeAlD
Adenosine triphosphate—ASNS—myometrium—ovarian cancer	0.000569	0.00384	CbGeAlD
Adenosine triphosphate—APAF1—lymph node—ovarian cancer	0.000568	0.00383	CbGeAlD
Adenosine triphosphate—ASNA1—gonad—ovarian cancer	0.000567	0.00383	CbGeAlD
Adenosine triphosphate—TNK2—decidua—ovarian cancer	0.000567	0.00382	CbGeAlD
Adenosine triphosphate—ASNA1—uterus—ovarian cancer	0.000564	0.0038	CbGeAlD
Adenosine triphosphate—ABCG1—female gonad—ovarian cancer	0.000563	0.0038	CbGeAlD
Adenosine triphosphate—AFG3L2—gonad—ovarian cancer	0.00056	0.00378	CbGeAlD
Adenosine triphosphate—ABCG1—vagina—ovarian cancer	0.00056	0.00377	CbGeAlD
Adenosine triphosphate—ACVRL1—vagina—ovarian cancer	0.00056	0.00377	CbGeAlD
Adenosine triphosphate—AFG3L2—uterus—ovarian cancer	0.000557	0.00375	CbGeAlD
Adenosine triphosphate—ADRBK2—testis—ovarian cancer	0.000551	0.00371	CbGeAlD
Adenosine triphosphate—AKT1—embryo—ovarian cancer	0.000547	0.00369	CbGeAlD
Adenosine triphosphate—NAE1—gonad—ovarian cancer	0.000547	0.00369	CbGeAlD
Adenosine triphosphate—HSPA1B—bone marrow—ovarian cancer	0.000545	0.00368	CbGeAlD
Adenosine triphosphate—HSPA1A—bone marrow—ovarian cancer	0.000545	0.00368	CbGeAlD
Adenosine triphosphate—NAE1—uterus—ovarian cancer	0.000543	0.00366	CbGeAlD
Adenosine triphosphate—ARAF—female reproductive system—ovarian cancer	0.00054	0.00364	CbGeAlD
Adenosine triphosphate—ACSS1—uterine cervix—ovarian cancer	0.000538	0.00363	CbGeAlD
Adenosine triphosphate—ABCC9—female gonad—ovarian cancer	0.000535	0.00361	CbGeAlD
Adenosine triphosphate—NT5C2—uterine cervix—ovarian cancer	0.000527	0.00355	CbGeAlD
Adenosine triphosphate—ACVR1—uterine cervix—ovarian cancer	0.000527	0.00355	CbGeAlD
Adenosine triphosphate—HSPA1A—female gonad—ovarian cancer	0.000526	0.00354	CbGeAlD
Adenosine triphosphate—HSPA1B—female gonad—ovarian cancer	0.000526	0.00354	CbGeAlD
Adenosine triphosphate—HSPA1A—Paclitaxel—Docetaxel—ovarian cancer	0.000525	0.125	CbGdCrCtD
Adenosine triphosphate—ACVR1B—female reproductive system—ovarian cancer	0.000524	0.00354	CbGeAlD
Adenosine triphosphate—HSPA1B—vagina—ovarian cancer	0.000522	0.00352	CbGeAlD
Adenosine triphosphate—HSPA1A—vagina—ovarian cancer	0.000522	0.00352	CbGeAlD
Adenosine triphosphate—ACSS2—uterine cervix—ovarian cancer	0.000516	0.00348	CbGeAlD
Adenosine triphosphate—ACSS1—decidua—ovarian cancer	0.000513	0.00346	CbGeAlD
Adenosine triphosphate—ACSL1—uterine cervix—ovarian cancer	0.000513	0.00346	CbGeAlD
Adenosine triphosphate—ARAF—bone marrow—ovarian cancer	0.00051	0.00344	CbGeAlD
Adenosine triphosphate—SLC25A4—gonad—ovarian cancer	0.000509	0.00343	CbGeAlD
Adenosine triphosphate—ABCA1—decidua—ovarian cancer	0.000507	0.00342	CbGeAlD
Adenosine triphosphate—ASNA1—female reproductive system—ovarian cancer	0.000507	0.00342	CbGeAlD
Adenosine triphosphate—ACVR1—decidua—ovarian cancer	0.000502	0.00338	CbGeAlD
Adenosine triphosphate—NT5C2—decidua—ovarian cancer	0.000502	0.00338	CbGeAlD
Adenosine triphosphate—AFG3L2—female reproductive system—ovarian cancer	0.0005	0.00337	CbGeAlD
Adenosine triphosphate—ABCG1—testis—ovarian cancer	0.0005	0.00337	CbGeAlD
Adenosine triphosphate—ACVRL1—testis—ovarian cancer	0.0005	0.00337	CbGeAlD
Adenosine triphosphate—TNK2—uterus—ovarian cancer	0.000496	0.00334	CbGeAlD
Adenosine triphosphate—ASS1—myometrium—ovarian cancer	0.000496	0.00334	CbGeAlD
Adenosine triphosphate—ACSS2—decidua—ovarian cancer	0.000492	0.00331	CbGeAlD
Adenosine triphosphate—ARAF—female gonad—ovarian cancer	0.000492	0.00331	CbGeAlD
Adenosine triphosphate—ARAF—vagina—ovarian cancer	0.000489	0.00329	CbGeAlD
Adenosine triphosphate—ACSL1—decidua—ovarian cancer	0.000488	0.00329	CbGeAlD
Adenosine triphosphate—NAE1—female reproductive system—ovarian cancer	0.000488	0.00329	CbGeAlD
Adenosine triphosphate—ACSS1—endometrium—ovarian cancer	0.000487	0.00328	CbGeAlD
Adenosine triphosphate—PRKAA1—uterine cervix—ovarian cancer	0.000485	0.00327	CbGeAlD
Adenosine triphosphate—ADCY1—testis—ovarian cancer	0.000484	0.00326	CbGeAlD
Adenosine triphosphate—ASNA1—bone marrow—ovarian cancer	0.000478	0.00323	CbGeAlD
Adenosine triphosphate—ACVR1B—female gonad—ovarian cancer	0.000477	0.00322	CbGeAlD
Adenosine triphosphate—NT5C2—endometrium—ovarian cancer	0.000476	0.00321	CbGeAlD
Adenosine triphosphate—ACVR1—endometrium—ovarian cancer	0.000476	0.00321	CbGeAlD
Adenosine triphosphate—ABCC9—testis—ovarian cancer	0.000475	0.0032	CbGeAlD
Adenosine triphosphate—AFG3L2—bone marrow—ovarian cancer	0.000472	0.00318	CbGeAlD
Adenosine triphosphate—ACSS2—endometrium—ovarian cancer	0.000467	0.00315	CbGeAlD
Adenosine triphosphate—HSPA1B—testis—ovarian cancer	0.000466	0.00314	CbGeAlD
Adenosine triphosphate—HSPA1A—testis—ovarian cancer	0.000466	0.00314	CbGeAlD
Adenosine triphosphate—ALK—female reproductive system—ovarian cancer	0.000464	0.00313	CbGeAlD
Adenosine triphosphate—ACSL1—endometrium—ovarian cancer	0.000464	0.00313	CbGeAlD
Adenosine triphosphate—ASNA1—female gonad—ovarian cancer	0.000461	0.00311	CbGeAlD
Adenosine triphosphate—NAE1—bone marrow—ovarian cancer	0.000461	0.00311	CbGeAlD
Adenosine triphosphate—ASNA1—vagina—ovarian cancer	0.000458	0.00309	CbGeAlD
Adenosine triphosphate—AFG3L2—female gonad—ovarian cancer	0.000455	0.00307	CbGeAlD
Adenosine triphosphate—SLC25A4—female reproductive system—ovarian cancer	0.000455	0.00307	CbGeAlD
Adenosine triphosphate—AFG3L2—vagina—ovarian cancer	0.000452	0.00305	CbGeAlD
Adenosine triphosphate—ADRBK1—gonad—ovarian cancer	0.000452	0.00304	CbGeAlD
Adenosine triphosphate—ACSS1—gonad—ovarian cancer	0.000452	0.00304	CbGeAlD
Adenosine triphosphate—AKT1—epithelium—ovarian cancer	0.000447	0.00301	CbGeAlD
Adenosine triphosphate—TNK2—female reproductive system—ovarian cancer	0.000446	0.00301	CbGeAlD
Adenosine triphosphate—NAE1—female gonad—ovarian cancer	0.000444	0.00299	CbGeAlD
Adenosine triphosphate—ASNS—uterine cervix—ovarian cancer	0.000443	0.00299	CbGeAlD
Adenosine triphosphate—AKT1—uterine cervix—ovarian cancer	0.000443	0.00299	CbGeAlD
Adenosine triphosphate—NT5C2—gonad—ovarian cancer	0.000442	0.00298	CbGeAlD
Adenosine triphosphate—NAE1—vagina—ovarian cancer	0.000441	0.00298	CbGeAlD
Adenosine triphosphate—ACVR1—uterus—ovarian cancer	0.000439	0.00296	CbGeAlD
Adenosine triphosphate—NT5C2—uterus—ovarian cancer	0.000439	0.00296	CbGeAlD
Adenosine triphosphate—ARAF—testis—ovarian cancer	0.000436	0.00294	CbGeAlD
Adenosine triphosphate—ADK—myometrium—ovarian cancer	0.000433	0.00292	CbGeAlD
Adenosine triphosphate—ACSS2—gonad—ovarian cancer	0.000433	0.00292	CbGeAlD
Adenosine triphosphate—ACSS2—uterus—ovarian cancer	0.00043	0.0029	CbGeAlD
Adenosine triphosphate—ACSL1—gonad—ovarian cancer	0.00043	0.0029	CbGeAlD
Adenosine triphosphate—ACSL1—uterus—ovarian cancer	0.000427	0.00288	CbGeAlD
Adenosine triphosphate—ACVR1B—testis—ovarian cancer	0.000423	0.00285	CbGeAlD
Adenosine triphosphate—AKT1—decidua—ovarian cancer	0.000422	0.00284	CbGeAlD
Adenosine triphosphate—ASNS—decidua—ovarian cancer	0.000422	0.00284	CbGeAlD
Adenosine triphosphate—SLC25A4—female gonad—ovarian cancer	0.000414	0.00279	CbGeAlD
Adenosine triphosphate—SLC25A4—vagina—ovarian cancer	0.000411	0.00277	CbGeAlD
Adenosine triphosphate—ASNA1—testis—ovarian cancer	0.000409	0.00276	CbGeAlD
Adenosine triphosphate—PRKAA1—gonad—ovarian cancer	0.000407	0.00274	CbGeAlD
Adenosine triphosphate—TNK2—female gonad—ovarian cancer	0.000406	0.00274	CbGeAlD
Adenosine triphosphate—AFG3L2—testis—ovarian cancer	0.000404	0.00272	CbGeAlD
Adenosine triphosphate—ADRBK1—female reproductive system—ovarian cancer	0.000403	0.00272	CbGeAlD
Adenosine triphosphate—ACSS1—female reproductive system—ovarian cancer	0.000403	0.00272	CbGeAlD
Adenosine triphosphate—AKT1—endometrium—ovarian cancer	0.0004	0.0027	CbGeAlD
Adenosine triphosphate—ASNS—endometrium—ovarian cancer	0.0004	0.0027	CbGeAlD
Adenosine triphosphate—ADRBK2—lymph node—ovarian cancer	0.000399	0.00269	CbGeAlD
Adenosine triphosphate—ABCA1—female reproductive system—ovarian cancer	0.000399	0.00269	CbGeAlD
Adenosine triphosphate—NT5C2—female reproductive system—ovarian cancer	0.000395	0.00266	CbGeAlD
Adenosine triphosphate—ACVR1—female reproductive system—ovarian cancer	0.000395	0.00266	CbGeAlD
Adenosine triphosphate—NAE1—testis—ovarian cancer	0.000394	0.00266	CbGeAlD
Adenosine triphosphate—ASS1—epithelium—ovarian cancer	0.000389	0.00262	CbGeAlD
Adenosine triphosphate—ACSS2—female reproductive system—ovarian cancer	0.000387	0.00261	CbGeAlD
Adenosine triphosphate—ASS1—uterine cervix—ovarian cancer	0.000386	0.0026	CbGeAlD
Adenosine triphosphate—ACSL1—female reproductive system—ovarian cancer	0.000384	0.00259	CbGeAlD
Adenosine triphosphate—ADRBK1—bone marrow—ovarian cancer	0.000381	0.00257	CbGeAlD
Adenosine triphosphate—ACSS1—bone marrow—ovarian cancer	0.000381	0.00257	CbGeAlD
Adenosine triphosphate—ALK—testis—ovarian cancer	0.000375	0.00253	CbGeAlD
Adenosine triphosphate—NT5C2—bone marrow—ovarian cancer	0.000373	0.00251	CbGeAlD
Adenosine triphosphate—ACVR1—bone marrow—ovarian cancer	0.000373	0.00251	CbGeAlD
Adenosine triphosphate—AKT1—gonad—ovarian cancer	0.000371	0.0025	CbGeAlD
Adenosine triphosphate—AKT1—uterus—ovarian cancer	0.000369	0.00249	CbGeAlD
Adenosine triphosphate—ASNS—uterus—ovarian cancer	0.000369	0.00249	CbGeAlD
Adenosine triphosphate—ASS1—decidua—ovarian cancer	0.000368	0.00248	CbGeAlD
Adenosine triphosphate—SLC25A4—testis—ovarian cancer	0.000367	0.00247	CbGeAlD
Adenosine triphosphate—ADRBK1—female gonad—ovarian cancer	0.000367	0.00247	CbGeAlD
Adenosine triphosphate—ACSS1—female gonad—ovarian cancer	0.000367	0.00247	CbGeAlD
Adenosine triphosphate—ACSS2—bone marrow—ovarian cancer	0.000365	0.00246	CbGeAlD
Adenosine triphosphate—ADRBK1—vagina—ovarian cancer	0.000365	0.00246	CbGeAlD
Adenosine triphosphate—ACSS1—vagina—ovarian cancer	0.000365	0.00246	CbGeAlD
Adenosine triphosphate—PRKAA1—female reproductive system—ovarian cancer	0.000364	0.00245	CbGeAlD
Adenosine triphosphate—ABCA1—female gonad—ovarian cancer	0.000363	0.00245	CbGeAlD
Adenosine triphosphate—ACSL1—bone marrow—ovarian cancer	0.000363	0.00244	CbGeAlD
Adenosine triphosphate—ABCG1—lymph node—ovarian cancer	0.000362	0.00244	CbGeAlD
Adenosine triphosphate—ACVRL1—lymph node—ovarian cancer	0.000362	0.00244	CbGeAlD
Adenosine triphosphate—HSPA1A—Vincristine—Vinorelbine—ovarian cancer	0.000361	0.0861	CbGdCrCtD
Adenosine triphosphate—ABCA1—vagina—ovarian cancer	0.000361	0.00243	CbGeAlD
Adenosine triphosphate—TNK2—testis—ovarian cancer	0.00036	0.00243	CbGeAlD
Adenosine triphosphate—NT5C2—female gonad—ovarian cancer	0.000359	0.00242	CbGeAlD
Adenosine triphosphate—ACVR1—female gonad—ovarian cancer	0.000359	0.00242	CbGeAlD
Adenosine triphosphate—NT5C2—vagina—ovarian cancer	0.000357	0.00241	CbGeAlD
Adenosine triphosphate—ACVR1—vagina—ovarian cancer	0.000357	0.00241	CbGeAlD
Adenosine triphosphate—ACSS2—female gonad—ovarian cancer	0.000352	0.00237	CbGeAlD
Adenosine triphosphate—ADCY1—lymph node—ovarian cancer	0.000351	0.00237	CbGeAlD
Adenosine triphosphate—ACSS2—vagina—ovarian cancer	0.00035	0.00236	CbGeAlD
Adenosine triphosphate—ACSL1—female gonad—ovarian cancer	0.000349	0.00236	CbGeAlD
Adenosine triphosphate—ASS1—endometrium—ovarian cancer	0.000349	0.00235	CbGeAlD
Adenosine triphosphate—ACSL1—vagina—ovarian cancer	0.000347	0.00234	CbGeAlD
Adenosine triphosphate—ABCC9—lymph node—ovarian cancer	0.000344	0.00232	CbGeAlD
Adenosine triphosphate—PRKAA1—bone marrow—ovarian cancer	0.000343	0.00231	CbGeAlD
Adenosine triphosphate—ABL2—female gonad—ovarian cancer	0.000343	0.00231	CbGeAlD
Adenosine triphosphate—ABL2—vagina—ovarian cancer	0.000341	0.0023	CbGeAlD
Adenosine triphosphate—HSPA1B—lymph node—ovarian cancer	0.000338	0.00228	CbGeAlD
Adenosine triphosphate—HSPA1A—lymph node—ovarian cancer	0.000338	0.00228	CbGeAlD
Adenosine triphosphate—ADK—uterine cervix—ovarian cancer	0.000337	0.00227	CbGeAlD
Adenosine triphosphate—AKT1—female reproductive system—ovarian cancer	0.000332	0.00224	CbGeAlD
Adenosine triphosphate—PRKAA1—female gonad—ovarian cancer	0.000331	0.00223	CbGeAlD
Adenosine triphosphate—ACSS1—testis—ovarian cancer	0.000325	0.00219	CbGeAlD
Adenosine triphosphate—ADRBK1—testis—ovarian cancer	0.000325	0.00219	CbGeAlD
Adenosine triphosphate—ASS1—gonad—ovarian cancer	0.000324	0.00218	CbGeAlD
Adenosine triphosphate—ABCA1—testis—ovarian cancer	0.000322	0.00217	CbGeAlD
Adenosine triphosphate—ASS1—uterus—ovarian cancer	0.000322	0.00217	CbGeAlD
Adenosine triphosphate—ADK—decidua—ovarian cancer	0.000321	0.00217	CbGeAlD
Adenosine triphosphate—ACVR1—testis—ovarian cancer	0.000319	0.00215	CbGeAlD
Adenosine triphosphate—NT5C2—testis—ovarian cancer	0.000319	0.00215	CbGeAlD
Adenosine triphosphate—ARAF—lymph node—ovarian cancer	0.000316	0.00213	CbGeAlD
Adenosine triphosphate—ASNS—bone marrow—ovarian cancer	0.000313	0.00211	CbGeAlD
Adenosine triphosphate—AKT1—bone marrow—ovarian cancer	0.000313	0.00211	CbGeAlD
Adenosine triphosphate—ACSS2—testis—ovarian cancer	0.000312	0.0021	CbGeAlD
Adenosine triphosphate—ABL1—myometrium—ovarian cancer	0.000312	0.0021	CbGeAlD
Adenosine triphosphate—ACSL1—testis—ovarian cancer	0.00031	0.00209	CbGeAlD
Adenosine triphosphate—ACVR1B—lymph node—ovarian cancer	0.000307	0.00207	CbGeAlD
Adenosine triphosphate—ADK—endometrium—ovarian cancer	0.000305	0.00206	CbGeAlD
Adenosine triphosphate—ABL2—testis—ovarian cancer	0.000304	0.00205	CbGeAlD
Adenosine triphosphate—ASNS—female gonad—ovarian cancer	0.000302	0.00204	CbGeAlD
Adenosine triphosphate—AKT1—female gonad—ovarian cancer	0.000302	0.00204	CbGeAlD
Adenosine triphosphate—AKT1—vagina—ovarian cancer	0.0003	0.00202	CbGeAlD
Adenosine triphosphate—ASNS—vagina—ovarian cancer	0.0003	0.00202	CbGeAlD
Adenosine triphosphate—ABL1—embryo—ovarian cancer	0.0003	0.00202	CbGeAlD
Adenosine triphosphate—ASNA1—lymph node—ovarian cancer	0.000296	0.002	CbGeAlD
Adenosine triphosphate—PRKAA1—testis—ovarian cancer	0.000293	0.00198	CbGeAlD
Adenosine triphosphate—AFG3L2—lymph node—ovarian cancer	0.000293	0.00197	CbGeAlD
Adenosine triphosphate—HSPA1A—Vinblastine—Vinorelbine—ovarian cancer	0.00029	0.0692	CbGdCrCtD
Adenosine triphosphate—ASS1—female reproductive system—ovarian cancer	0.000289	0.00195	CbGeAlD
Adenosine triphosphate—NAE1—lymph node—ovarian cancer	0.000286	0.00193	CbGeAlD
Adenosine triphosphate—ADK—gonad—ovarian cancer	0.000283	0.00191	CbGeAlD
Adenosine triphosphate—ABCC8—endometrium—ovarian cancer	0.000283	0.00191	CbGeAlD
Adenosine triphosphate—ALK—lymph node—ovarian cancer	0.000272	0.00183	CbGeAlD
Adenosine triphosphate—AKT1—testis—ovarian cancer	0.000268	0.00181	CbGeAlD
Adenosine triphosphate—ASNS—testis—ovarian cancer	0.000268	0.00181	CbGeAlD
Adenosine triphosphate—SLC25A4—lymph node—ovarian cancer	0.000266	0.00179	CbGeAlD
Adenosine triphosphate—ASS1—female gonad—ovarian cancer	0.000263	0.00177	CbGeAlD
Adenosine triphosphate—ASS1—vagina—ovarian cancer	0.000262	0.00176	CbGeAlD
Adenosine triphosphate—TNK2—lymph node—ovarian cancer	0.000261	0.00176	CbGeAlD
Adenosine triphosphate—ADK—female reproductive system—ovarian cancer	0.000253	0.0017	CbGeAlD
Adenosine triphosphate—ABCB11—testis—ovarian cancer	0.000249	0.00168	CbGeAlD
Adenosine triphosphate—ABL1—uterine cervix—ovarian cancer	0.000243	0.00164	CbGeAlD
Adenosine triphosphate—ADK—bone marrow—ovarian cancer	0.000238	0.00161	CbGeAlD
Adenosine triphosphate—ADRBK1—lymph node—ovarian cancer	0.000236	0.00159	CbGeAlD
Adenosine triphosphate—ACSS1—lymph node—ovarian cancer	0.000236	0.00159	CbGeAlD
Adenosine triphosphate—ASS1—testis—ovarian cancer	0.000233	0.00157	CbGeAlD
Adenosine triphosphate—ABCA1—lymph node—ovarian cancer	0.000233	0.00157	CbGeAlD
Adenosine triphosphate—ABL1—decidua—ovarian cancer	0.000231	0.00156	CbGeAlD
Adenosine triphosphate—NT5C2—lymph node—ovarian cancer	0.000231	0.00156	CbGeAlD
Adenosine triphosphate—ACVR1—lymph node—ovarian cancer	0.000231	0.00156	CbGeAlD
Adenosine triphosphate—ADK—female gonad—ovarian cancer	0.00023	0.00155	CbGeAlD
Adenosine triphosphate—ADK—vagina—ovarian cancer	0.000228	0.00154	CbGeAlD
Adenosine triphosphate—ACSS2—lymph node—ovarian cancer	0.000226	0.00152	CbGeAlD
Adenosine triphosphate—ACSL1—lymph node—ovarian cancer	0.000225	0.00151	CbGeAlD
Adenosine triphosphate—ABL2—lymph node—ovarian cancer	0.00022	0.00149	CbGeAlD
Adenosine triphosphate—ABL1—endometrium—ovarian cancer	0.000219	0.00148	CbGeAlD
Adenosine triphosphate—PRKAA1—lymph node—ovarian cancer	0.000213	0.00143	CbGeAlD
Adenosine triphosphate—ADK—testis—ovarian cancer	0.000204	0.00137	CbGeAlD
Adenosine triphosphate—ABL1—gonad—ovarian cancer	0.000204	0.00137	CbGeAlD
Adenosine triphosphate—ABL1—uterus—ovarian cancer	0.000202	0.00136	CbGeAlD
Adenosine triphosphate—AKT1—lymph node—ovarian cancer	0.000194	0.00131	CbGeAlD
Adenosine triphosphate—ASNS—lymph node—ovarian cancer	0.000194	0.00131	CbGeAlD
Adenosine triphosphate—ABCC8—testis—ovarian cancer	0.000189	0.00127	CbGeAlD
Adenosine triphosphate—ABL1—female reproductive system—ovarian cancer	0.000182	0.00123	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Epirubicin—ovarian cancer	0.000176	0.0419	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Epirubicin—ovarian cancer	0.000176	0.0419	CbGdCrCtD
Adenosine triphosphate—ABL1—bone marrow—ovarian cancer	0.000172	0.00116	CbGeAlD
Adenosine triphosphate—ASS1—lymph node—ovarian cancer	0.000169	0.00114	CbGeAlD
Adenosine triphosphate—ABL1—female gonad—ovarian cancer	0.000165	0.00112	CbGeAlD
Adenosine triphosphate—ABL1—vagina—ovarian cancer	0.000164	0.00111	CbGeAlD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—ovarian cancer	0.000163	0.0388	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—ovarian cancer	0.000163	0.0388	CbGdCrCtD
Adenosine triphosphate—ABCC2—female reproductive system—ovarian cancer	0.000157	0.00106	CbGeAlD
Adenosine triphosphate—ADK—lymph node—ovarian cancer	0.000148	0.000996	CbGeAlD
Adenosine triphosphate—ABL1—testis—ovarian cancer	0.000147	0.000989	CbGeAlD
Adenosine triphosphate—ABL1—Idarubicin—Epirubicin—ovarian cancer	0.000133	0.0318	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Epirubicin—ovarian cancer	0.000133	0.0318	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Epirubicin—ovarian cancer	0.000133	0.0318	CbGdCrCtD
Adenosine triphosphate—ABCC2—testis—ovarian cancer	0.000127	0.000855	CbGeAlD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—ovarian cancer	0.000123	0.0294	CbGdCrCtD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—ovarian cancer	0.000123	0.0294	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—ovarian cancer	0.000123	0.0294	CbGdCrCtD
Adenosine triphosphate—ABL1—lymph node—ovarian cancer	0.000106	0.000717	CbGeAlD
Adenosine triphosphate—ABCB1—myometrium—ovarian cancer	9.69e-05	0.000654	CbGeAlD
Adenosine triphosphate—ABCB1—embryo—ovarian cancer	9.32e-05	0.000629	CbGeAlD
Adenosine triphosphate—ABCC2—lymph node—ovarian cancer	9.19e-05	0.00062	CbGeAlD
Adenosine triphosphate—ABCB1—epithelium—ovarian cancer	7.61e-05	0.000513	CbGeAlD
Adenosine triphosphate—ABCB1—uterine cervix—ovarian cancer	7.54e-05	0.000509	CbGeAlD
Adenosine triphosphate—ABCB1—decidua—ovarian cancer	7.19e-05	0.000485	CbGeAlD
Adenosine triphosphate—ABCB1—endometrium—ovarian cancer	6.82e-05	0.00046	CbGeAlD
Adenosine triphosphate—ABCB1—gonad—ovarian cancer	6.33e-05	0.000427	CbGeAlD
Adenosine triphosphate—ABCB1—uterus—ovarian cancer	6.29e-05	0.000424	CbGeAlD
Adenosine triphosphate—ABCB1—female reproductive system—ovarian cancer	5.65e-05	0.000381	CbGeAlD
Adenosine triphosphate—ABCB1—bone marrow—ovarian cancer	5.34e-05	0.00036	CbGeAlD
Adenosine triphosphate—ABCB1—female gonad—ovarian cancer	5.14e-05	0.000347	CbGeAlD
Adenosine triphosphate—ABCB1—vagina—ovarian cancer	5.11e-05	0.000345	CbGeAlD
Adenosine triphosphate—ABCB1—testis—ovarian cancer	4.56e-05	0.000308	CbGeAlD
Adenosine triphosphate—ABCB1—lymph node—ovarian cancer	3.31e-05	0.000223	CbGeAlD
Adenosine triphosphate—AKT1—Adaptive Immune System—KRAS—ovarian cancer	3.64e-06	2e-05	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—AKT1—ovarian cancer	3.63e-06	1.99e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PIK3CD—ovarian cancer	3.62e-06	1.99e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CDKN1B—ovarian cancer	3.62e-06	1.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—ERBB2—ovarian cancer	3.6e-06	1.97e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—KRAS—ovarian cancer	3.6e-06	1.97e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MAPK3—ovarian cancer	3.59e-06	1.97e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—HRAS—ovarian cancer	3.58e-06	1.96e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MAPK1—ovarian cancer	3.57e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—EGFR—ovarian cancer	3.56e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PIK3CB—ovarian cancer	3.55e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MTOR—ovarian cancer	3.55e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—ovarian cancer	3.55e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CASP3—ovarian cancer	3.55e-06	1.94e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL2—ovarian cancer	3.54e-06	1.94e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PIK3CD—ovarian cancer	3.53e-06	1.93e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PTEN—ovarian cancer	3.52e-06	1.93e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—PIK3CA—ovarian cancer	3.52e-06	1.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CXCL8—ovarian cancer	3.5e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KRAS—ovarian cancer	3.5e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—IL6—ovarian cancer	3.49e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MYC—ovarian cancer	3.49e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—PIK3CA—ovarian cancer	3.49e-06	1.91e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—HRAS—ovarian cancer	3.46e-06	1.9e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CCND1—ovarian cancer	3.45e-06	1.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ERBB2—ovarian cancer	3.45e-06	1.89e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.45e-06	1.89e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CTNNB1—ovarian cancer	3.42e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MAPK1—ovarian cancer	3.42e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—EGFR—ovarian cancer	3.42e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CXCL8—ovarian cancer	3.41e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MTOR—ovarian cancer	3.41e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PIK3CB—ovarian cancer	3.41e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—HRAS—ovarian cancer	3.4e-06	1.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—HRAS—ovarian cancer	3.39e-06	1.86e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PIK3CD—ovarian cancer	3.38e-06	1.85e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ERBB2—ovarian cancer	3.37e-06	1.85e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—KRAS—ovarian cancer	3.37e-06	1.85e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CG—ovarian cancer	3.36e-06	1.84e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MMP9—ovarian cancer	3.35e-06	1.84e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—PIK3CA—ovarian cancer	3.35e-06	1.84e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL2—ovarian cancer	3.35e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—PIK3CA—ovarian cancer	3.35e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.34e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CDKN1B—ovarian cancer	3.33e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TERT—ovarian cancer	3.33e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTEN—ovarian cancer	3.33e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PIK3CB—ovarian cancer	3.33e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—MTOR—ovarian cancer	3.33e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—IL6—ovarian cancer	3.31e-06	1.82e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—PIK3CA—ovarian cancer	3.3e-06	1.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—AKT1—ovarian cancer	3.3e-06	1.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CXCL8—ovarian cancer	3.27e-06	1.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CASP3—ovarian cancer	3.27e-06	1.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL2—ovarian cancer	3.26e-06	1.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—HRAS—ovarian cancer	3.25e-06	1.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL6—ovarian cancer	3.25e-06	1.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KRAS—ovarian cancer	3.23e-06	1.77e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HRAS—ovarian cancer	3.22e-06	1.77e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTEN—ovarian cancer	3.22e-06	1.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—PIK3CA—ovarian cancer	3.21e-06	1.76e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERBB2—ovarian cancer	3.2e-06	1.75e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CDKN1B—ovarian cancer	3.2e-06	1.75e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCND1—ovarian cancer	3.18e-06	1.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—AKT1—ovarian cancer	3.16e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PIK3CB—ovarian cancer	3.16e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MTOR—ovarian cancer	3.16e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CTNNB1—ovarian cancer	3.15e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CASP3—ovarian cancer	3.13e-06	1.72e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL2—ovarian cancer	3.13e-06	1.72e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDKN1B—ovarian cancer	3.13e-06	1.71e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—YAP1—ovarian cancer	3.12e-06	1.71e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ERBB2—ovarian cancer	3.12e-06	1.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL6—ovarian cancer	3.11e-06	1.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HRAS—ovarian cancer	3.1e-06	1.7e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HRAS—ovarian cancer	3.1e-06	1.7e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PIK3CA—ovarian cancer	3.09e-06	1.7e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MMP9—ovarian cancer	3.09e-06	1.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—IL6—ovarian cancer	3.09e-06	1.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CAV1—ovarian cancer	3.08e-06	1.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MTOR—ovarian cancer	3.07e-06	1.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PIK3CB—ovarian cancer	3.07e-06	1.69e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTEN—ovarian cancer	3.07e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL2—ovarian cancer	3.06e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HRAS—ovarian cancer	3.06e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—AKT1—ovarian cancer	3.06e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCND1—ovarian cancer	3.05e-06	1.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CTNNB1—ovarian cancer	3.02e-06	1.66e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—VEGFA—ovarian cancer	3.01e-06	1.65e-05	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—AKT1—ovarian cancer	3e-06	1.65e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—AKT1—ovarian cancer	3e-06	1.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—AKT1—ovarian cancer	3e-06	1.64e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—STAT3—ovarian cancer	2.98e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NRAS—ovarian cancer	2.97e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ESR1—ovarian cancer	2.97e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HRAS—ovarian cancer	2.97e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL6—ovarian cancer	2.97e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PIK3CA—ovarian cancer	2.97e-06	1.63e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDKN1B—ovarian cancer	2.96e-06	1.62e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MMP9—ovarian cancer	2.96e-06	1.62e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CD—ovarian cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CTNNB1—ovarian cancer	2.95e-06	1.62e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PIK3CB—ovarian cancer	2.95e-06	1.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTEN—ovarian cancer	2.94e-06	1.61e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—IL6—ovarian cancer	2.93e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL6ST—ovarian cancer	2.92e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL2—ovarian cancer	2.9e-06	1.59e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CDKN1B—ovarian cancer	2.89e-06	1.58e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PTEN—ovarian cancer	2.88e-06	1.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—AKT1—ovarian cancer	2.87e-06	1.57e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HRAS—ovarian cancer	2.86e-06	1.57e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MAPK3—ovarian cancer	2.85e-06	1.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL6—ovarian cancer	2.84e-06	1.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.82e-06	1.55e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—APC—ovarian cancer	2.81e-06	1.54e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CG—ovarian cancer	2.81e-06	1.54e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—NRAS—ovarian cancer	2.81e-06	1.54e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CTNNB1—ovarian cancer	2.8e-06	1.53e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—VEGFA—ovarian cancer	2.77e-06	1.52e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MYC—ovarian cancer	2.77e-06	1.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—STAT3—ovarian cancer	2.75e-06	1.51e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HRAS—ovarian cancer	2.74e-06	1.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NRAS—ovarian cancer	2.74e-06	1.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—IL6—ovarian cancer	2.74e-06	1.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—AKT1—ovarian cancer	2.74e-06	1.5e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PTEN—ovarian cancer	2.73e-06	1.5e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CTNNB1—ovarian cancer	2.73e-06	1.49e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MAPK1—ovarian cancer	2.71e-06	1.49e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EGFR—ovarian cancer	2.71e-06	1.49e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—AKT1—ovarian cancer	2.7e-06	1.48e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—MAPK3—ovarian cancer	2.69e-06	1.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—VEGFA—ovarian cancer	2.66e-06	1.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTEN—ovarian cancer	2.66e-06	1.46e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—STAT3—ovarian cancer	2.63e-06	1.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NRAS—ovarian cancer	2.63e-06	1.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—IL6—ovarian cancer	2.63e-06	1.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—AKT1—ovarian cancer	2.62e-06	1.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MAPK3—ovarian cancer	2.62e-06	1.44e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CB—ovarian cancer	2.57e-06	1.41e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—STAT3—ovarian cancer	2.57e-06	1.41e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NRAS—ovarian cancer	2.57e-06	1.41e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—MAPK1—ovarian cancer	2.56e-06	1.4e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—EGFR—ovarian cancer	2.56e-06	1.4e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KRAS—ovarian cancer	2.56e-06	1.4e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MYC—ovarian cancer	2.55e-06	1.4e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTEN—ovarian cancer	2.55e-06	1.4e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—FASN—ovarian cancer	2.54e-06	1.39e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—AKT1—ovarian cancer	2.53e-06	1.39e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MAPK3—ovarian cancer	2.52e-06	1.38e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—SLC5A5—ovarian cancer	2.5e-06	1.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MAPK1—ovarian cancer	2.5e-06	1.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EGFR—ovarian cancer	2.5e-06	1.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PIK3CA—ovarian cancer	2.48e-06	1.36e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CD—ovarian cancer	2.47e-06	1.35e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—MAPK3—ovarian cancer	2.46e-06	1.35e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—PIK3CA—ovarian cancer	2.45e-06	1.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MYC—ovarian cancer	2.45e-06	1.34e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MAPK3—ovarian cancer	2.44e-06	1.34e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—STAT3—ovarian cancer	2.44e-06	1.34e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NRAS—ovarian cancer	2.43e-06	1.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—AKT1—ovarian cancer	2.42e-06	1.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KRAS—ovarian cancer	2.42e-06	1.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—SLC2A1—ovarian cancer	2.41e-06	1.32e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MAPK1—ovarian cancer	2.39e-06	1.31e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EGFR—ovarian cancer	2.39e-06	1.31e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MYC—ovarian cancer	2.38e-06	1.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—STAT3—ovarian cancer	2.38e-06	1.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NRAS—ovarian cancer	2.37e-06	1.3e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KRAS—ovarian cancer	2.36e-06	1.29e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PIK3CA—ovarian cancer	2.35e-06	1.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—MAPK1—ovarian cancer	2.34e-06	1.28e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EGFR—ovarian cancer	2.34e-06	1.28e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MAPK3—ovarian cancer	2.33e-06	1.28e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP1B1—ovarian cancer	2.31e-06	1.27e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—ovarian cancer	2.27e-06	1.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PIK3CA—ovarian cancer	2.27e-06	1.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MAPK3—ovarian cancer	2.27e-06	1.24e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KRAS—ovarian cancer	2.26e-06	1.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTEN—ovarian cancer	2.22e-06	1.22e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—PIK3CA—ovarian cancer	2.22e-06	1.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MAPK1—ovarian cancer	2.22e-06	1.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EGFR—ovarian cancer	2.22e-06	1.22e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KRAS—ovarian cancer	2.21e-06	1.21e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MYC—ovarian cancer	2.21e-06	1.21e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ERBB2—ovarian cancer	2.18e-06	1.2e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—HRAS—ovarian cancer	2.18e-06	1.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PIK3CA—ovarian cancer	2.17e-06	1.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MAPK1—ovarian cancer	2.16e-06	1.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EGFR—ovarian cancer	2.16e-06	1.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MTOR—ovarian cancer	2.15e-06	1.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CB—ovarian cancer	2.15e-06	1.18e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—ovarian cancer	2.1e-06	1.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KRAS—ovarian cancer	2.09e-06	1.15e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL6—ovarian cancer	2.08e-06	1.14e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PIK3CA—ovarian cancer	2.08e-06	1.14e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCL8—ovarian cancer	2.07e-06	1.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—HRAS—ovarian cancer	2.06e-06	1.13e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PPP2R1A—ovarian cancer	2.05e-06	1.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KRAS—ovarian cancer	2.04e-06	1.12e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PIK3CA—ovarian cancer	2.03e-06	1.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—AKT1—ovarian cancer	2.03e-06	1.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CDKN1B—ovarian cancer	2.02e-06	1.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—ovarian cancer	2.01e-06	1.1e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—HRAS—ovarian cancer	2e-06	1.1e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CASP3—ovarian cancer	1.98e-06	1.09e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL2—ovarian cancer	1.98e-06	1.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL6—ovarian cancer	1.97e-06	1.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCND1—ovarian cancer	1.93e-06	1.06e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PIK3CA—ovarian cancer	1.92e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—HRAS—ovarian cancer	1.92e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—AKT1—ovarian cancer	1.92e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL6—ovarian cancer	1.92e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CTNNB1—ovarian cancer	1.91e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HRAS—ovarian cancer	1.88e-06	1.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PIK3CA—ovarian cancer	1.87e-06	1.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—TYMS—ovarian cancer	1.87e-06	1.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MMP9—ovarian cancer	1.87e-06	1.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTEN—ovarian cancer	1.86e-06	1.02e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—AKT1—ovarian cancer	1.86e-06	1.02e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL6—ovarian cancer	1.84e-06	1.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL6—ovarian cancer	1.8e-06	9.85e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PIK3CA—ovarian cancer	1.8e-06	9.84e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HRAS—ovarian cancer	1.78e-06	9.76e-06	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—AKT1—ovarian cancer	1.77e-06	9.7e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HRAS—ovarian cancer	1.73e-06	9.51e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL6—ovarian cancer	1.7e-06	9.34e-06	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—AKT1—ovarian cancer	1.7e-06	9.3e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VEGFA—ovarian cancer	1.68e-06	9.21e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—STAT3—ovarian cancer	1.66e-06	9.12e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NRAS—ovarian cancer	1.66e-06	9.1e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—IL6—ovarian cancer	1.66e-06	9.1e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MAPK3—ovarian cancer	1.59e-06	8.71e-06	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—AKT1—ovarian cancer	1.57e-06	8.62e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CA—ovarian cancer	1.57e-06	8.6e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MYC—ovarian cancer	1.55e-06	8.48e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MAPK1—ovarian cancer	1.51e-06	8.29e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EGFR—ovarian cancer	1.51e-06	8.29e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CAV1—ovarian cancer	1.51e-06	8.27e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—AKT1—ovarian cancer	1.47e-06	8.04e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KRAS—ovarian cancer	1.43e-06	7.83e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.37e-06	7.53e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CA—ovarian cancer	1.31e-06	7.19e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—ovarian cancer	1.27e-06	6.96e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HRAS—ovarian cancer	1.21e-06	6.66e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.21e-06	6.62e-06	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL6—ovarian cancer	1.16e-06	6.37e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.05e-06	5.77e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTEN—ovarian cancer	9.1e-07	4.99e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CA—ovarian cancer	6.42e-07	3.52e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKT1—ovarian cancer	5.24e-07	2.87e-06	CbGpPWpGaD
